-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Maintains Overweight on CG Oncology, Raises Price Target to $85

Benzinga·08/07/2026 16:54:59
Listen to the news
Piper Sandler analyst Kelsey Goodwin maintains CG Oncology (NASDAQ:CGON) with a Overweight and raises the price target from $82 to $85.